Australia markets open in 7 hours 19 minutes

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
33.83-0.33 (-0.97%)
As of 11:38AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
132
9,434
18,437
32,166
6,829
Cost of revenue
0
-
-
-
0
Gross profit
3,500
-
-
-
6,829
Operating expenses
Research development
147,817
105,767
75,463
50,523
38,845
Selling general and administrative
38,449
32,810
21,967
12,944
10,803
Total operating expenses
186,266
138,577
97,430
63,467
49,648
Operating income or loss
-186,134
-129,143
-78,993
-31,301
-42,819
Interest expense
-
0
0
484
1,434
Total other income/expenses net
3,547
3,888
105
2,207
282
Income before tax
-163,111
-125,255
-78,888
-29,094
-41,618
Income tax expense
622
118
-6
-257
-23
Income from continuing operations
-163,733
-125,373
-78,882
-28,837
-41,595
Net income
-163,733
-125,373
-78,882
-28,837
-41,595
Net income available to common shareholders
-163,681
-124,936
-77,087
-28,013
-40,027
Basic EPS
-
-2.06
-1.77
-0.81
-1.54
Diluted EPS
-
-2.06
-1.77
-0.81
-1.54
Basic average shares
-
60,542
43,627
34,542
25,939
Diluted average shares
-
60,542
43,627
34,542
25,939